Disclosure profile

Who’s trading MORN?

Morningstar, Inc.

Every disclosed Congress and corporate-insider transaction in MORN (Morningstar, Inc.): 35 trades from 15 politicians and executives, each AI-scored. Updated as new filings land.

Create a free account to open trades, see the full AI breakdown, and get live alerts when MORN is traded.

Create a free account →

FilerActionAmountFiledScore

Mansueto Joseph DSEC Form 4Sell$1.9M2026-08-144

Mansueto Joseph DSEC Form 4Sell$1.5M2026-08-124

Mansueto Joseph DSEC Form 4Sell$452k2026-08-073

Mansueto Joseph DSEC Form 4—$100k2026-08-054

Morningstar, Inc. (MORN) (CIK 0001289419)SEC 13GSell—2026-08-053

Lyons William MSEC Form 4Sell$199k2026-08-034

Morningstar, Inc. (MORN) (CIK 0001289419)SEC Form 144Buy$19.9M2026-08-037

Morningstar, Inc. (MORN) (CIK 0001289419)SEC 13GSell—2026-08-032

Morningstar, Inc. (MORN) (CIK 0001289419)SEC Form 144Buy$199k2026-08-034

Hon. April McClain DelaneyHouse PTRSell$1k2026-06-057

Morningstar, Inc. (MORN) (CIK 0001289419)SEC Form 144Buy—2026-05-274

Lyons William MSEC Form 4Sell—2026-05-273

Mansueto Joseph DSEC Form 4Sell—2026-05-204

BRAMMAN ANNE LSEC Form 4——2026-05-195

TSAY CAROLINE JSEC Form 4——2026-05-195

Sutton DonielSEC Form 4——2026-05-195

Kaplan Steven NSEC Form 4——2026-05-193

Holt MichaelSEC Form 4——2026-05-194

Wiersema ConanSEC Form 4——2026-05-195

Kapoor KunalSEC Form 4——2026-05-197

FRANCIS CHERYL ASEC Form 4——2026-05-194

Lyons William MSEC Form 4——2026-05-195

JOYNT STEPHENSEC Form 4——2026-05-194

Diamonte RobinSEC Form 4——2026-05-194

Morningstar, Inc. (MORN) (CIK 0001289419)SEC Form 144Buy—2026-05-124

Morningstar, Inc. (MORN)SEC 8-K——2026-05-086

Hon. April McClain DelaneyHouse PTRSell$1k2026-05-067

Mansueto Joseph DSEC Form 4Sell—2026-05-046

Morningstar, Inc. (MORN) (CIK 0001289419)SEC Form 144Buy—2026-05-013

Hon. April McClain DelaneyHouse PTRSell$1k2026-03-107

Hon. April McClain DelaneyHouse PTRSell$1k2026-02-027

Hon. April McClain DelaneyHouse PTRBuy$15k2025-09-028

Public-record disclosures (SEC Form 4 & Congressional PTRs). Research tool, not investment advice.